Pramipexole – Dopamine Agonist for Parkinson’s Disease & RLS
Pramipexole is a prescription dopamine agonist that mimics the action of dopamine in the brain. It is commonly used to treat Parkinson’s disease by improving motor symptoms such as tremors, rigidity, and bradykinesia (slow movement). Pramipexole is also FDA‑approved for moderate‑to‑severe Restless Legs Syndrome (RLS) , helping reduce the urge to move the legs and improving sleep quality. By stimulating dopamine receptors (primarily D2 and D3 subtypes), it helps restore proper neurological signaling in conditions associated with dopamine deficiency.
Key Benefits:
-
Reduces Parkinson’s motor symptoms
-
Relieves Restless Legs Syndrome discomfort
-
Available as immediate‑release and extended‑release tablets



